Trademark information
IP India · live recordApplication ID
993486
Status
Registered
Sub status
Not Applicable
Date of application
28 February 2001
Classes
5
Type
Word
Proprietor
Maneesh Pharmaceuticals Public
29 33, Ancillary Industrial Plots, Govandi, Mumbai 400 043
Agent
R.K. Dewan & Co.[11306]78, Podar Chembers, S.A. Brelvi Road, Fort, Bombay 400 001.
State
Maharashtra
Filing mode
Branch Office
IP office
Mumbai
Used since
—
Valid / upto
28 February 2031
Goods & services
Class 5Class 5MEDICINAL, PHARMACEUTICALS AND VETERINARY PREPARATIONS.
PR details
REGISTRATION RENEWED FOR A PERIOD OF 10 YEARS FROM 28/02/2011 ADVERTISED IN JOURNAL NO. 1474
PURSUANT TO A REQUEST ON FORM TM-24 DATED 31/01/2014 AND ORDER THEREON DATED 10/02/2017 MANEESH PHARMACEUTICALS LTD. HAS BEEN BROUGHT ON RECORD AS SUBSEQUENT PROPRIETOR IN RESPECT OF THE SAID REGISTERED TRADE MARK BY VIRTUE DEED OF ASSIGNMENT DATED 03/05/2005 AND 07/05/2005.
REGISTRATION RENEWED FOR A PERIOD OF 10 YEARS FROM 28/02/2021 ADVERTISED IN JOURNAL NO. 1990
Uploaded documents
Sign in to open
1
Additional Representation Sheet
25 Mar 1980
2
Certificate
27 Feb 2001
2
Journal Copy
27 Feb 2001
3
Note Sheet
27 Feb 2001
3
Certificate
27 Feb 2001
4
Other Documents
27 Feb 2001
5
Journal Copy
27 Feb 2001
5
TM-1
27 Feb 2001
6
Certificate
27 Feb 2001
6
Note Sheet
27 Feb 2001
6
TM-1
27 Feb 2001
7
TM-12
11 Feb 2011
8
TM-P(SUBSEQUENT PROPRIETOR BY WAY OF ASSIGNMENT OR TRANSFER OF A SINGLE MARK)
31 Dec 2020
9
TM-R(RENEWAL OF TRADE MARK)
11 Feb 2021
10
Notices
22 Sep 2022
11
Letters related to POST REGISTRATION
28 Oct 2022
12
Notices
26 Nov 2025
Correspondence and notices
1
O3 NOTICE
10839262 · 5072240
17 Dec 2020
2
RENEWAL INTIMATION LETTER
11177832
26 Feb 2021
3
Intimation Letter to proprietor
21211150 · 7500230
24 Nov 2025
Frequently asked questions
Phencodin was applied for on 28 February 2001.
The application was filed by Maneesh Pharmaceuticals.
Class 5.
As per IP India, the status is Registered.
The listed application ID of Phencodin is 993486.
Trademark attorney R.K. Dewan & Co.